Ludmilla Kasulke (Nee Savelieff)
🏛️ Revolving DoorFormer Government Position:
2003- Intern Sen. DeWine; Jan. 06-May 06: Intern, WH Council on Environ. Quality; May 06-April 07: Ex. Assist., Chairman, WH Council on Environmental Quality; April 07-Jan. 09: Special Assist., Chairman, WH Council on Environmental Quality
🤖
AI Overview
Ludmilla Kasulke (Nee Savelieff) has appeared in 398 federal lobbying filings at Squire Patton Boggs, representing 49 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 34 policy areas.
398
Total Filings
1
Firms
49
Clients
34
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 21 | 10 |
| 2019 | 34 | 11 |
| 2020 | 23 | 8 |
| 2021 | 21 | 8 |
| 2022 | 58 | 12 |
| 2023 | 76 | 12 |
| 2024 | 56 | 11 |
| 2025 | 109 | 22 |
Firms
Squire Patton Boggs398 filings
Top Clients
Sk Hynix America, INC.57 filings
Sk Americas, INC.34 filings
Mars Incorporated28 filings
American Conservation Coalition Action23 filings
Teijin Aramid USA INC17 filings
Bunge North America, INC.13 filings
Autos Drive America11 filings
Zippo Manufacturing Company10 filings
Vertiv Group Corporation10 filings
Ktm North America, INC.8 filings
City of San Diego8 filings
Wanhua Chemical US Holdings INC.6 filings
Match Group6 filings
Jabil, INC.6 filings
Cma Cgm (America) Llc/advocacy6 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The 22,000% ROI
When lobbying spending yields outsized returns.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.